<DOC>
	<DOCNO>NCT03067792</DOCNO>
	<brief_summary>Patients diagnosis inoperable gastric cancer treat palliative chemotherapy . Palliative chemotherapy proven well overall survival quality life unresectable advanced gastric cancer . NCCN guideline suggest two three drug cytotoxic regimen first line therapy . But response rate regimens 50 percent . Disappointingly case experience progression disease . Second line regimen palliative chemotherapy also show efficacy recommend within patient good performance status . But There still lack evidence gastric cancer patient second line chemotherapy . Several phase II trial subject 2nd line palliative chemotherapy gastric cancer suggest irinotecan , taxane , oxaliplatin , oral fluorouracil.Investigator assess whether cisplatin combination paclitaxel would increase response rate patient previously treat advanced gastric cancer compare FOFIRI regimen .</brief_summary>
	<brief_title>FOLFIRI Versus Docetaxel Cisplatin Second-line Chemotherapy After Failure First-line Chemotherapy Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1 . Older 19 year old young 75 year old 2 . Pathologically confirm gastric cancer 3 . Inoperable stage diagnosis 4. experienced disease progression first line palliative chemotherapy 5 . ECOG performance status 0 1 6 . Adequate renal function ( serum creatinine &lt; 1.5 mg/dL calculate creatinine clearance ≥ 60 ml/min ) 7 . Adequate liver function ( total bilirubin &lt; 1.5 X upper limit normal ( ULN ) , AST ALT &lt; 3 X UNL , alkaline phosphatase &lt; 3 X ULN &lt; 5 x ULN case liver involvement ) 8 . Adequate BM function ( WBC ≥ 3,500/µl , absolute neutrophil cell count ≥ 1,500 /µl , platelet count ≥ 100,000/µl ) 9 . Subjects give write informed consent give full description study 1. double primary cancer gastric cancer 2. history palliative radiation therapy 3 . Pregnant breast feed 4 . Neuropathy grade &gt; 3 5 . Active infection 6 . Symptomatic cardiopulmonary disease 7 . Active hepatitis liver cirrhosis 8 . Impaired renal function 9 . Impaired psychologic bone marrow function 10 . Psychologic disorder , Severe neurologic disorder . 11. hypersensitivity chemotherapeutic agent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>inoperable gastric cancer</keyword>
	<keyword>palliative chemotherapy</keyword>
</DOC>